The ASCO presentation will include a more mature data cut than that described in the abstract and will include safety and initial efficacy data for the 100mg casdatifan once-daily (QD) plus 60mg ...

Explore the comprehensive report detailing 11+ companies and pipeline drugs. Key areas include drug profiles, clinical stages, and therapeutic assessments. Discover emerging therapeutics from major ...

The Japanese pharmaceutical company Taiho Pharmaceutical Co., Ltd. has entered into an agreement to acquire the Swiss biotech company Araris Biotech AG. This is reported in a press release from 4BIO ...

PRINCETON, N.J., April 23, 2025 /PRNewswire/ -- Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced today that ...

“This is the third agreement established by Araris, after the successful collaboration with Taiho Pharmaceutical announced in November 2023, and with Chugai Pharmaceutical Co., Ltd most recently ...

Japanese drugmaker Shionogi said on Wednesday that it will acquire Torii Pharmaceutical , a subsidiary of Japan Tobacco , for ...

HERZLIYA, Israel and CALGARY, AB, May 6, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer ...

Innocan's first fully-granted patent in Mexico Covers Innocan's proprietary cannabis-based pain relief topical Indication of Innocan's growing intellectual property portfolio This patent covers a ...

Bain Capital bought Mitsubishi Tanabe Pharma for $3.5 billion while Blackstone acquired a majority stake in one of Japan’s ...

"We are excited to enter the next phase of Ousia Pharma's journey, advancing our groundbreaking platform towards clinical development," said Anders B. Klein, PhD, CEO of Ousia Pharma. "The strong ...

BERLIN, May 05, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of ...